MedTrace Logo

18F-NaF Uptake and Aortic Stenosis Progression

NCT02740088 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2016-04-15

No results posted yet for this study

Summary

This study aims to evaluate whether baseline 18F-sodium fluoride uptake activity at aortic valve could predict aortic stenosis progression in moderate aortic stenosis.

Patients with moderate aortic stenosis are enrolled and underwent baseline evaluation including 18F-sodium fluoride PET/CT. After 1 year, all the participants underwent follow-up echocardiography. The study design is an observational trial. Primary endpoint was a change in mean pressure gradient along the aortic valve as assessed by echocardiography at 1 year. Secondary endpoints include changes in aortic valve area, and symptom occurrence.

Conditions

  • Aortic Stenosis

Interventions

OTHER

Imaging test: 18F-NaF PET/CT

18F-NaF PET/CT as an imaging test

Sponsors & Collaborators

  • Seoul St. Mary's Hospital

    lead OTHER

Principal Investigators

  • Ho-Joong Youn, MD · Seoul St. Mary's Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-08-31
Completion
2017-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02740088 on ClinicalTrials.gov